retatrutide triple agonist gip glp-1 glucagon receptor Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide vs. Tirzepatide: The Next-Gen

This innovative oral GLP-1 is a small molecule medication that, unlike the Wegovy pill, doesnt require that you take it on an empty stomach.

Glucagon-like peptide 1 (GLP-1) is a cleavage product of the pre-proglucagon gene which is expressed in the -cells of the pancreas, the L-cells of the intestine, and neurons located in the caudal brainstem and hypothalamus

Despite these findings, a clear link has yet to be established, and much of the evidence remains inconsistent

These actions improve glycemic control and support weight loss

Are you a candidate?

Tirzepatide, a novel GLP-1/GIP dual receptor agonist, shows significant advantages in glycemic management and weight control